Which biologic therapy is selected for allergic asthma based on elevated IgE levels?

In peak flow monitoring, what does the ‘yellow zone’ (50-80% of personal best) indicate?

A patient’s asthma remains poorly controlled, and after optimizing ICS-containing therapy and trying other add-on options, the provider is considering adding montelukast. What must occur before starting this medication?

A 62-year-old patient has type 2 diabetes, meets criteria for metabolic syndrome, and has an LDL-C of 165 mg/dL. Synthesizing diagnostic criteria and treatment approaches across diabetes, metabolic syndrome, and lipid management, what is the most comprehensive evidence-based plan?

A 58-year-old patient with type 2 diabetes and a 10-year ASCVD risk of 12% is being evaluated for comprehensive cardiovascular risk reduction. Integrating statin therapy criteria, blood pressure management, and current aspirin guidance, what is the most complete evidence-based plan?

A patient presents with several weeks of cough, occupational exposure to agricultural chemicals, and progressive dyspnea. Integrating the systematic etiology approach for respiratory complaints with red-flag recognition principles, what is the most comprehensive evidence-based evaluation approach?

A patient with chronic kidney disease taking an ACE inhibitor develops hyperkalemia with peaked T waves on EKG. Integrating the causes of hyperkalemia with the distinction between emergency and chronic management, what is the most appropriate synthesis of care for this patient?

No levothyroxine, since it is contraindicated in cardiac disease

A patient with type 2 diabetes and established coronary artery disease has an A1C of 6.9%, already near target on metformin alone. Based on comorbidity-driven treatment principles, should additional therapy be considered?

What are the three primary lipid parameters of clinical concern, and how are LDL-C and HDL-C commonly remembered?